Repligen | RGEN - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Agilent USD 476M 48M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
Bio Techne USD 113.69M 2.52M 2025-12
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Bruker USD 247.2M 4.7M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Danaher USD 2.03B 35M 2025-12
Dentsply International USD 383M 28M 2025-12
General Electric Aerospace USD 1.58B 385M 2025-12
Henry Schein USD 808M 48M 2025-12
Illumina USD 283M 27M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
Mettler Toledo International USD 259.83M 11.43M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Pfizer USD 4.08B 894M 2025-12
Repligen USD 74.36M 703K 2025-12
Revvity USD 251.73M 9.82M 2025-12
Standard Biotools USD 21.55M 5.05M 2025-12
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Waters USD 240.01M 25.78M 2025-12
West Pharmaceutical Services USD 106.5M 3.8M 2025-12